<code id='973AE109D3'></code><style id='973AE109D3'></style>
    • <acronym id='973AE109D3'></acronym>
      <center id='973AE109D3'><center id='973AE109D3'><tfoot id='973AE109D3'></tfoot></center><abbr id='973AE109D3'><dir id='973AE109D3'><tfoot id='973AE109D3'></tfoot><noframes id='973AE109D3'>

    • <optgroup id='973AE109D3'><strike id='973AE109D3'><sup id='973AE109D3'></sup></strike><code id='973AE109D3'></code></optgroup>
        1. <b id='973AE109D3'><label id='973AE109D3'><select id='973AE109D3'><dt id='973AE109D3'><span id='973AE109D3'></span></dt></select></label></b><u id='973AE109D3'></u>
          <i id='973AE109D3'><strike id='973AE109D3'><tt id='973AE109D3'><pre id='973AE109D3'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:67
          The building exterior of AstraZeneca, a pharmaceutical and biopharmaceutical company, under cloudless blue sky — coverage from STAT
          Adobe

          WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. It didn’t go well for them.

          AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process. But Colm Connolly, chief judge of the U.S. District Court of Delaware, said he doesn’t understand how the law deprives AstraZeneca of its property. He asked Catherine Stetson, who represents AstraZeneca, multiple times to explain what property the company would lose due to Medicare price negotiation. Stetson said it’s both the patent and the drug that’s subject to the patent.

          advertisement

          “You’re free to do what you want,” Connolly said, adding that drug companies don’t have to sell to Medicare. “You may not make as much money.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          He's a Nobel laureate. Critics say he was misleading on Covid
          He's a Nobel laureate. Critics say he was misleading on Covid

          Photoillustration:AlexHogan/STAT;Sourcephoto:AFPviaGettyOnedaylastAugust,astheystruggledtofigureoutw

          read more
          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more

          Merck, Daiichi strike cancer drug pact worth up to $22 billion

          KenaBetancur/GettyImagesMADRID—MerckispayingbillionsofdollarstopartnerwithDaiichiSankyoonaseriesofca